These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 16612398)

  • 1. Contrast-induced nephrotoxicity: clinical landscape.
    Katzberg RW; Haller C
    Kidney Int Suppl; 2006 Apr; (100):S3-7. PubMed ID: 16612398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical epidemiology of contrast-induced nephropathy.
    Parfrey P
    Cardiovasc Intervent Radiol; 2005; 28 Suppl 2():S3-11. PubMed ID: 16419277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nephrotoxicity related to contrast media.
    Berg KJ
    Scand J Urol Nephrol; 2000 Oct; 34(5):317-22. PubMed ID: 11186471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative Effect of Contrast Media Type on the Incidence of Contrast-Induced Nephropathy: A Systematic Review and Meta-analysis.
    Eng J; Wilson RF; Subramaniam RM; Zhang A; Suarez-Cuervo C; Turban S; Choi MJ; Sherrod C; Hutfless S; Iyoha EE; Bass EB
    Ann Intern Med; 2016 Mar; 164(6):417-24. PubMed ID: 26830055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contrast Media-Different Types of Contrast Media, Their History, Chemical Properties, and Relative Nephrotoxicity.
    Lohani S; Rudnick MR
    Interv Cardiol Clin; 2020 Jul; 9(3):279-292. PubMed ID: 32471669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ionic low-osmolar versus nonionic iso-osmolar contrast media to obviate worsening nephropathy after angioplasty in chronic renal failure patients: the ICON (Ionic versus non-ionic Contrast to Obviate worsening Nephropathy after angioplasty in chronic renal failure patients) study.
    Mehran R; Nikolsky E; Kirtane AJ; Caixeta A; Wong SC; Teirstein PS; Downey WE; Batchelor WB; Casterella PJ; Kim YH; Fahy M; Dangas GD
    JACC Cardiovasc Interv; 2009 May; 2(5):415-21. PubMed ID: 19463464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent issues in contrast-induced nephropathy.
    Kitajima K; Maeda T; Watanabe S; Sugimura K
    Int J Urol; 2011 Oct; 18(10):686-90. PubMed ID: 21834851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal safety of iodixanol.
    McCullough PA
    Expert Rev Cardiovasc Ther; 2006 Sep; 4(5):655-61. PubMed ID: 17081087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What are radiologists doing to prevent contrast-induced nephropathy (CIN) compared with measures supported by current evidence? A survey of European radiologists on CIN associated with computed tomography.
    Fishman EK; Reddan D
    Acta Radiol; 2008 Apr; 49(3):310-20. PubMed ID: 18365820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contrast-induced nephropathy: definition, epidemiology, and patients at risk.
    Mehran R; Nikolsky E
    Kidney Int Suppl; 2006 Apr; (100):S11-5. PubMed ID: 16612394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High incidence of nephropathy in neurosurgical patients after intra-arterial administration of low-osmolar and iso-osmolar contrast media.
    Serafin Z; Karolkiewicz M; Gruszka M; Strózecki P; Lasek W; Odrowaz-Sypniewska G; Manitius J; Beuth W
    Acta Radiol; 2011 May; 52(4):422-9. PubMed ID: 21498279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contrast-induced nephropathy.
    Persson PB
    Eur Radiol; 2005 Nov; 15 Suppl 4():D65-9. PubMed ID: 16479650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of contrast material-induced nephropathy after neuroendovascular procedures.
    Prasad V; Gandhi D; Stokum C; Miller T; Jindal G
    Radiology; 2014 Dec; 273(3):853-8. PubMed ID: 25102293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrast media and nephropathy: findings from systematic analysis and Food and Drug Administration reports of adverse effects.
    Solomon R; Dumouchel W
    Invest Radiol; 2006 Aug; 41(8):651-60. PubMed ID: 16829749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of iso-osmolar contrast use in emergent percutaneous coronary intervention for ST-segment elevation myocardial infarction.
    Kanei Y; Ayabe K; Ratcliffe J; Vales L; Nakra N; Friedman P; Fox J
    J Invasive Cardiol; 2011 Nov; 23(11):448-50. PubMed ID: 22045075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computerized tomography contrast induced nephropathy (CIN) among adult inpatients.
    Diogo LP; Bahlis LF; Carvalhal GF
    J Bras Nefrol; 2014; 36(4):446-50. PubMed ID: 25517272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The challenges in assessing contrast-induced nephropathy: where are we now?
    Davenport MS; Cohan RH; Khalatbari S; Ellis JH
    AJR Am J Roentgenol; 2014 Apr; 202(4):784-9. PubMed ID: 24660707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-function relationships of iodinated contrast media and risk of nephrotoxicity.
    Stratta P; Quaglia M; Airoldi A; Aime S
    Curr Med Chem; 2012; 19(5):736-43. PubMed ID: 22204333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrast media induced nephropathy: definition, incidence, outcome, pathophysiology, risk factors and prevention.
    Feldkamp T; Kribben A
    Minerva Med; 2008 Apr; 99(2):177-96. PubMed ID: 18431326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Contrast-induced nephropathy].
    Santos RO; Malvar B; Silva R; Ramalho V; Pessegueiro P; Amoedo M; Aniceto J; Pires C
    Acta Med Port; 2011; 24(5):809-20. PubMed ID: 22525634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.